# Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients

> **NCT01334099** · PHASE1 · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 6 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **BIOLOGICAL:** CP-675,206
- **RADIATION:** External local radiation therapy

## Key facts

- **NCT ID:** NCT01334099
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2013-03
- **Final completion:** —
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Contract with drug supplier expired and was not renewed.
- **Last updated:** 2015-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01334099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01334099, "Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01334099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*